Emerald Advisers, LLC Avrobio, Inc. Transaction History

Emerald Advisers, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$5.53 - $9.28 $3.81 Million - $6.39 Million	-689,002 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$7.84 - $12.6 $1.79 Million - $2.88 Million	-228,220 Reduced 24.88%	689,002 $6.13 Million
Q1 2021 Apr 29, 2021	SELL	$10.54 - $19.3 $969,574 - $1.78 Million	-91,990 Reduced 9.12%	917,222 $11.6 Million
Q4 2020 Jan 29, 2021	BUY	$12.79 - $17.1 $2.59 Million - $3.47 Million	202,691 Added 25.13%	1,009,212 $14.1 Million
Q3 2020 Oct 28, 2020	SELL	$12.99 - $19.41 $337,129 - $503,747	-25,953 Reduced 3.12%	806,521 $10.5 Million
Q2 2020 Jul 28, 2020	BUY	$12.19 - $22.96 $461,647 - $869,518	37,871 Added 4.77%	832,474 $14.5 Million
Q1 2020 Apr 30, 2020	BUY	$10.08 - $27.21 $1.39 Million - $3.76 Million	138,297 Added 21.07%	794,603 $12.4 Million
Q4 2019 Jan 29, 2020	SELL	$13.05 - $21.88 $22,837 - $38,290	-1,750 Reduced 0.27%	656,306 $13.2 Million
Q3 2019 Oct 31, 2019	BUY	$14.12 - $23.44 $819,778 - $1.36 Million	58,058 Added 9.68%	658,056 $9.29 Million
Q2 2019 Jul 31, 2019	SELL	$13.21 - $27.29 $190,356 - $393,248	-14,410 Reduced 2.35%	599,998 $9.76 Million
Q1 2019 May 01, 2019	BUY	$12.46 - $22.05 $2.91 Million - $5.15 Million	233,772 Added 61.42%	614,408 $13.5 Million
Q4 2018 Jan 30, 2019	BUY	$15.43 - $32.7 $34,902 - $73,967	2,262 Added 0.6%	380,636 $6.34 Million
Q3 2018 Oct 31, 2018	BUY	$26.95 - $52.7 $3.74 Million - $7.31 Million	138,714 Added 57.88%	378,374 $19.6 Million
Q2 2018 Jul 31, 2018	BUY	$28.08 - $31.2 $6.73 Million - $7.48 Million	239,660 New	239,660 $6.85 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.